Pharmacist, Murtaza Abdulkarim (L) administers a temporary Strazeneca / Ox XF ford covid-19 vaccine to a patient at a temporary vaccination center on February 4 at the Al-Abbas Islamic Center in Birmingham, West Midlands. , 2021.
Oli scarf | AFP | Getty Images
LONDON – The first real-world data from the UK’s inoculation program has provided insight into how effective the vaccine against Covid-19 is.
The vaccine, developed by Pfizer and Bioentech Vaccine, was the first shot to be approved and rolled out in the UK in December. More than 80, health care workers and care home staff were in the first line for vaccination. Shortly afterwards a shot developed by the British Frim AstraZeneca and Oxford University followed.
Here are four charts summarizing how effective these vaccines are and how they are doing their part in the fight against the epidemic:
Declining deaths over the age of 85
Elderly people were the first to be vaccinated, since December 8, it is noteworthy that covid mortality is declining the fastest among those age groups. The chart below looks at Kovid’s death for Scotland, with the pace of the vaccination program picking up as the 85-over group saw a decline. Click here for full data.
Increase in antibodies
A blood test study published last week by Imperial College College London shows that around 14% of the British population now has antibodies against coronavirus. While this does not necessarily mean having an immune system, it was interesting to see the results of the people who were vaccinated and how high their antibody levels were. 18,000 participants of 155,000 individual studies were vaccinated and the results are in the chart below. Click here for full data.
A separate study from England found that the percentage of people who tested positive for antibodies was 801 per cent, which statisticians said was “largely due to the high rate of vaccination in this group.”
The real world effectiveness of Pfizer shots
Public Health England noted in detail how effective the Pfizer-Bioentech vaccine has been so far in protecting against therapeutic disease. The chart below shows that a single dose is 57% effective in protecting against pathological covid-19 disease in people over the age of 80 (28 days after the first dose).
The effectiveness of the vaccine is calculated using mathematical statistics called barrier ratio, click here for complete data and method.
… and the AstraZeneca vaccine
Public Health Scotland also collects data on the AstraZeneca-inxford vaccine for all age groups. The chart shows that, by the fourth week after receiving the first dose, the Pfizer-Bioentech and Ox-Oxford-AstraZeneca vaccines reduced the risk of hospitalization from Covid-19 by 85% and 94%, respectively. Click here for data and complete method.
Since the start of the vaccination rollout, the UK has vaccinated all of its top four priority groups with a view to achieving the goal. His goal now is to vaccinate all adults by mid-April, and by the end of July, two months ahead of the previous target.
As of Sunday, 20 million people had received their first dose of the vaccine, and about 800,000 people had received both doses, according to government data.
The UK’s vaccination program has been widely hailed as a victory in the midst of tragedy; More than 1.1 million infections have been reported worldwide, followed by the United States, India, Brazil and Russia, with 12,083 deaths, the fifth highest in the world, according to Johns Hopkins University.
Brian Bache of CNBC contributed to this article.
.
